source
- Safety concerns emerge as radiopharmaceuticals advance in cancer trialsRadiopharmaceuticals are being hailed for their ability to deliver radiation directly to tumours, potentially sparing surrounding healthy tissue and improving cancer therapy. However, as more cand…
- AbCellera women’s health data top ‘most aggressive upside scenario,’ putting Astellas and Bayer on noticeAbCellera has reported phase 2 results “beyond even the most aggressive upside scenario” that its CEO dared to consider, boosting the biotech’s chances of challenging Astellas and Bayer for a women…Fierce Biotech · 6h ago↗ source
- Silence brings the noise to Takeda with phase 2 blood cancer win